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a  b  s  t  r  a  c  t
The  analytical  method  outlined  in this  feasibility  study  has  been  used  to show  that trivalent  chromium
(Cr(III))  and  hexavalent  chromium  (Cr(VI))  can  be  detected  and  measured  in  exhaled  breath  condensate
(EBC)  samples.  EBC samples  and  urine  samples  were  collected  from  a cohort  of 58  workers  occupationally
exposed  to hexavalent  chromium  compounds  and  22  unexposed  volunteers  (control  group).  Levels  of
Cr(III) and  Cr(VI)  were  determined  in  EBC  samples  and  total  chromium  levels  were  determined  in urine
samples.  Pre  and  post  working  week  samples  for both  EBC  and urine  were  collected  in tandem.  Total
chromium  in urine  samples  was  analysed  by inductively  coupled  plasma  mass  spectrometry  (ICP-MS).
Analysis  of  Cr(III)  and  Cr(VI)  in  EBC  samples  used  a  hyphenated  micro  liquid  chromatography  (LC)
system  coupled  to  an ICP-MS.  Separation  was  achieved  using  an anion  exchange  micro-sized  column.
The  results  showed  that  the occupationally  exposed  workers  had  signiﬁcantly  higher levels  of  Cr(III)  and
Cr(VI) in  their  EBC  samples  than  the control  group,  as well  as higher  levels  of  total  chromium  in their  urine
samples.  However,  for  the  exposed  workers  no signiﬁcant  difference  was  found  between  pre and  post
working  week  EBC  samples  for  either  Cr(III) or Cr(VI).  This study  has  established  that  Cr(III) and  Cr(VI)  can
simultaneously  be  detected  and  measured  in  ‘real’  EBC  samples  and  will help in  understanding  inhalation
exposure.
Crown Copyright  © 2016  Published  by  Elsevier  GmbH.  This  is  an  open  access  article  under  the  Open
Government  License  (OGL)  (http://www.nationalarchives.gov.uk/doc/open-government-licence/. Introduction
In Great Britain (GB), many activities/occupations can involve
he use of chemicals considered hazardous to worker health. It
s important that exposure to chemicals which are classiﬁed as
arcinogens, mutagens and sensitisers be reduced to as low as
easonably practicable as stated in legislation (Health & Safety
xecutive (HSE), 2013a). Biological monitoring (the measurement
f a chemical or its breakdown products in a biological sample) is
Abbreviations: EBC, exhaled breath condensate; Cr(III), trivalent chromium;
r(VI), hexavalent chromium; ICP-MS, inductively coupled plasma mass spectrome-
ry; LC, micro liquid chromatography; COSHH, control of substances hazardous to
ealth; ATSDR, agency for toxic substances and disease registry; IARC, international
gency for research on cancer; HSE, Health & Safety Executive; RBC, red blood cells;
SL, Health and Safety Laboratory; BMGV, biological monitoring guidance value.
∗ Corresponding author at: Health & Safety Executive, Harpur Hill, Buxton SK17
JN, UK.
E-mail address: Liz.leese@hsl.gsi.gov.uk (E. Leese).
ttp://dx.doi.org/10.1016/j.ijheh.2016.12.003
438-4639/Crown Copyright © 2016 Published by Elsevier GmbH. This is an open access
ov.uk/doc/open-government-licence/version/3/).version/3/).
one approach for assessing occupational exposure to a chemical in
the workplace.
Hexavalent chromium (Cr(VI)), which includes chromates,
dichromates and chromic acid is one such chemical that is clas-
siﬁed as both a sensitising agent and a carcinogen (Agency for
toxic substances and disease registry (ATSDR), 2012; International
agency for research on cancer (IARC), 2016)). Exposure to Cr(VI)
compounds in the workplace can be through inhalation directly
into the lungs from breathing in dust, fumes or mists; dermal
absorption through the skin by contact with chromium solutions
or solids; or by ingestion as a result of hand to mouth contamina-
tion from handling food, smoking or biting nails when hands are
contaminated with chromium dust or solutions. Exposure to Cr(VI)
compounds can cause respiratory irritations such as nosebleeds,
ulcers and holes in the nasal septum, inﬂammatory respiratory
problems, skin irritation and rashes from allergic dermatitis, upset
stomachs, kidney and liver damage along with lung and nasal can-
cer (ATSDR, 2012; HSE, 2013b; Rakhunde et al., 2012). The types
of industry and commercial processes where occupational expo-
 article under the Open Government License (OGL) (http://www.nationalarchives.
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ure to Cr(VI) compounds might occur are chromate production,
roduction of chromate pigments and dyes, electroplating and ano-
ising, the production of stainless steel and other chromium alloys,
he cutting, ﬁnishing and welding of chromium alloys and stainless
teel, leather tanning and the production and spraying of paints
sed in the aeronautic and maritime industries (Genovese et al.,
015; HSE, 2013b; Rakhunde et al., 2012).
Exposure to Cr(VI) compounds leads to accumulation in vari-
us tissues such as the lungs, liver and kidneys (Genovese et al.,
015), with glutathione and ascorbate being responsible for reduc-
ion of Cr(VI) to trivalent chromium (Cr(III)) within cells with the
id of cysteine (De Flora et al., 1989; Paustenbach et al., 2003).
r(III) is an essential element as it is needed for the regulation and
etabolism of glucose, sugars and fats (Genovese et al., 2015) and
hus is considered non-toxic. This difference in toxicity between
he two chromium species is largely related to their permeability
nto cells. Although Cr(III) is more reactive than Cr(VI) (e.g. bind-
ng to DNA), Cr(III) is unable to permeate cell membranes, Cr(VI)
owever is easily taken up by cells; where it undergoes sequen-
ial reduction from Cr(V) to Cr(IV) and ﬁnally Cr(III) (De Flora et al.,
989; Hoet, 2005). Although exposure to Cr(VI) can be measured
n red blood cells (RBC) determined as Cr(III), reduction of Cr(VI)
o Cr(III) primarily occurs in plasma, reducing the uptake of Cr(VI)
nto RBC (Hoet, 2005). For the purposes of biological monitoring
or exposure assessment, a urine sample is widely accepted, largely
ue to it being less invasive and easier to collect than a blood sam-
le. All detectable chromium in a urine sample will be in the form
f Cr(III) (De Flora, 2000) and although this is not an ideal approach
o Cr(VI) exposure assessment, it is a practical one and widely used.
 background unexposed reference range of <2.9 mol/mol crea-
inine (Morton et al., 2014) has been established by HSE’s, Health
nd Safety Laboratory, and a Biological Monitoring Guidance Value
BMGV) of 10 mol/mol creatinine has been determined, based on
 Health & Safety Executive (HSE) study where the 90th percentile
as adopted from workplaces deemed to have good control (HSE,
011). Urinary chromium levels can reﬂect both past and recent
xposure, with daily accumulation through the working week of
he occupationally exposed (Hoet, 2005). Studies have suggested
he excretion of chromium in urine after exposure by inhalation
s a two or three stage process (Hoet, 2005; Petersen et al., 2000),
ith elimination half-lives of 7 h, 15–30 days and 3–5 years (ATSDR,
012; Hoet, 2005).
The main route of exposure to hexavalent chromium is by
nhalation (De Flora, 2000; Hoet, 2005) so a suitable biologi-
al matrix to represent exposure by inhalation to hexavalent
hromium compounds might be exhaled breath condensate (EBC).
fter an inhalation exposure of chromium into the lungs, it is
artially removed by mucociliary clearance, but some is known
o remain (Hoet, 2005). The exact bioavailability of respirable
hromium is not known, however animal studies have shown that
3–85% of respirable Cr(VI) is cleared from the lungs by absorption
nto the blood stream or by mucociliary clearance in comparison
o only 5–30% of respirable Cr(III), with the rest remaining in the
ungs (ATSDR, 2012). The collection and measurement of EBC is a
romising technique primarily due to its non-invasiveness and the
ack of interfering solutes found in other biological matrices. EBC
s the collection of condensate from cooled exhaled breath during
egular tidal breathing. This collected exhaled air contains mostly
ater vapour but also droplets of ﬂuid from the respiratory tract
Corradi and Mutti, 2005), meaning EBC measurements will reﬂect
arkers and molecules found in the mouth, tracheobronchial sys-
em and the alveoli (Kharitonov and Barnes, 2001). EBC is reported
o contain both volatile substances in the gaseous phase along with
ow volatile and non-volatile substances in the form of droplets
riginating from the epithelial lining ﬂuid, as aerosol particles
n EBC (Rosias, 2012). The non-volatile substances will include Environmental Health 220 (2017) 415–423
salts, proteins, lipids and environmental and/or occupational
contaminants (Corradi and Mutti, 2005; Goldoni et al., 2013;
Kharitonov and Barnes, 2001).
There are only a small number of studies concerning the rela-
tionship between EBC measurements and occupational exposure,
where detectable levels of metals in EBC have been reported such
as; for cobalt and tungsten (Broding et al., 2009; Goldoni et al.,
2004), beryllium (Hulo et al., 2016), manganese (Hulo et al., 2014),
lead (Felix et al., 2015) and iron, nickel, aluminium and chromium
(Caglieri et al., 2006; Goldoni et al., 2010; Goldoni et al., 2006; Gube
et al., 2010; Hoffmeyer et al., 2011). To date there are only two
published studies where Cr(VI) was  measured in EBC samples of
workers (Goldoni et al., 2010; Goldoni et al., 2006), however both
used a method combining solvent extraction with complexation
with diphenylcarbazide and measurement performed by atomic
absorption spectrometry. There are no publications measuring
Cr(VI) by inductively coupled plasma – mass spectrometry (ICP-
MS)  and there are no publications reporting the measurement of
Cr(III) in EBC samples of workers or background populations.
We have previously validated and published our novel analytical
methodology in which the two chromium species were determined
in EBC samples (Leese et al., 2016). The objective of this feasibility
study was to determine if both Cr(III) and Cr(VI) could be detected
and measured in ‘real’ EBC samples. Having collected samples the
aim was to determine whether there was  a difference between the
levels of Cr(III) and Cr(VI) found in EBC samples between a control
group not occupationally exposed to chromium compounds and
an occupational group who are potentially occupationally exposed
to Cr(VI) compounds by inhalation. In addition, any difference in
chromium EBC levels would be investigated between pre and post
working week samples from the occupationally exposed volun-
teers.
2. Experimental
2.1. Study group
The occupationally exposed group (n = 58) consisted of 53 males
and 5 females, all were over the age of 18 years, with a mean age
of 45 years. Individuals volunteered in response to an email sent to
companies who had previously sent urine samples to the Health
& Safety Laboratory for chromium analysis as part of a biologi-
cal monitoring program. The occupationally exposed workers were
categorised into three types of workers and termed Cr(VI) Workers,
Non-Cr(VI) Workers and Other Workers;
Cr(VI) Workers – Individuals who  work directly with chromium
compounds (e.g. Cr(VI) platers, jiggers and blenders).
Non-Cr(VI) Workers – Individuals who  did not work directly
with chromium compounds, but worked alongside colleagues
working directly with chromium (e.g. nickel, silver or copper elec-
troplaters, maintenance).
Other Workers – Individuals who work neither with chromium
nor alongside chromium workers (e.g. inspectors, administration
staff, and managers).
Table 1 shows all the types of occupations detailed by the occu-
pationally exposed workers and in which of the three worker
categories they were placed in this study.
The volunteers in the control group (n = 22) consisted of 16
males and 6 females, who  were not occupationally exposed to
Cr(VI) compounds. All were over the age of 18 years, with a mean
age of 39 years. Individuals volunteered in response to an email
request outlining the study, sent to staff at the Health & Safety
Laboratory.
The study was approved by the NHS Research Ethics Committee
London – Camden & Islington, REC number 14/LO/1273. All partici-
E. Leese et al. / International Journal of Hygiene and
Table  1
Types of occupational or workplace role listed on the questionnaire by all individual
volunteers potentially exposed to occupational Cr(VI) compounds.
Cr(VI) Workers
Chrome electroplater
Grinder
Plasma cutter
Blenders (chemical production of powders, liquids or solids)
Anodiser
Jigger
Passivater
Polisher
Non-Cr(VI) Workers (not working directly with chromium)
General area duties
Silver electroplating
Nickel electroplater & electroless-plater
Copper plater
Zinc plater
Tin plater
Lab analyst
Other Workers
Production Team Leader
Inspector
Manager
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POfﬁce worker
Supervisor
ating volunteers gave informed consent, and were provided with
 participant information sheet. Volunteer information was  col-
ected via a questionnaire. Information collected included: gender,
ge and smoking status, and for the occupationally exposed group
nly; tasks and duties undertaken since providing the pre working
eek sample. Because this is a feasibility study only, information
n length of employment status and instances of work related ill
ealth were not obtained.
For the occupationally exposed workers, workplace site visits
ere conducted by the authors to collect both a urine and EBC
ample from each volunteer on a Monday morning at the start of
hift (pre working week) and again on a Thursday afternoon (post
orking week).
For the control group, urine samples and EBC samples were col-
ected onsite at the Health and Safety Laboratory. Urine and EBC
amples were collected from each control volunteer at the begin-
ing of the week and again at the end of the working week as was
one for the occupationally exposed group.
.2. Instrumentation
All sample analysis was undertaken using inductively coupled
lasma – mass spectrometry (ICP-MS). Both total chromium in
rine and chromium species Cr(III) and Cr(VI) in EBC samples were
etermined using an XSERIES 2 ICP-MS (Thermo Fisher Scientiﬁc,
emel Hempstead, UK) monitoring 52Cr. For both methods the ICP-
S was operated in collision cell (CCT) mode using 7% hydrogen in
elium, RF power 1400 W,  using Ni Xt skimmer and sample cones.
he ICP-MS conditions were optimised daily.
.2.1. EBC samples – chromium speciation
Speciation analysis was performed using a hyphenated LC sys-
em with the XSERIES2 ICP-MS. The separation of Cr(III) and Cr(VI)
as achieved using a 5 cm anion exchange column, (Dionex AG7
 mm × 50 mm i.d., 10 m,  Thermo Fisher Scientiﬁc, Hemel Hemp-
tead, UK). The delivery of both sample and mobile phase onto the
olumn was accomplished using an ESI OneFAST system (Elemen-
al Scientiﬁc, Warrington, UK), with the ICP-MS peristaltic pump
ontrolling a constant ﬂow rate of 1 mL/min, with a six port switch-
ng value and 500 L sample loop. The operating conditions of the
LC-ICP-MS were: nebuliser gas ﬂow rate 0.86–0.96 L/min using a
FA-ST nebuliser (Elemental Scientiﬁc, Warrington, UK), collision Environmental Health 220 (2017) 415–423 417
gas ﬂow rate 3.4–3.7 mL/min, dwell time of 100 ms  for 52Cr. The
speciﬁc conditions of the LC-ICP-MS method used in this study
and the optimised conditions for the collection, stability and anal-
ysis of Cr(III) and Cr(VI) in EBC have been reported elsewhere (Leese
et al., 2016).
2.2.2. Urine samples – total chromium
Analysis was  performed on the XSERIES2 ICP-MS using a
Burgener Miramist (Burgener Research Inc., Ontario, Canada)
nebuliser. Operating conditions were: nebuliser gas ﬂow rate
0.81–0.96 L/min, collision gas ﬂow rate 3.5 mL/min, dwell times
were 100 ms  for 52Cr and 20 ms  for 72Ge (internal standard), with
100 sweeps per replicate and three replicates per sample.
2.3. Reagents
Potassium dichromate (K2Cr2O7) (analytical grade),
chromium(III) chloride (CrCl3)(laboratory grade) and EDTA
(diaminoethanetetracetic acid) were obtained from Fisher Sci-
entiﬁc (Loughborough, UK). SpA ammonia solution (NH3) and
UpA Nitric Acid were obtained from Romil (Cambridge, UK). BDH
ICP-MS single standards of 1000 mg/L chromium and germanium
were obtained from VWR  International (Lutterworth, UK).
All solutions were prepared fresh each day of analysis using
ultrapure deionised water (18.2 Mhm  cm) from a Millipore sys-
tem (Merck Millipore, Billerica, MA,  USA).
2.4. Sample collection
All urine samples were collected in 25 mL urine collection bot-
tles (Sterilin Ltd, Newport, UK). EBC samples were collected using
a TURBO-DECCS (Transportable Unit for Research on Biomarkers
Obtained from Disposable Exhaled Condensate Collection Systems)
by ItalChill (Parma, Italy). The TURBO-DECCS technique is as previ-
ously described (Leese et al., 2016). Immediately after the collection
of each EBC sample an aliquot of EBC was diluted 10 fold with the
0.5 mM EDTA (pH was  adjusted to pH 8 using 10% v/v aqueous
ammonia solution) solution onsite by the authors. Urine and EBC
samples were returned to the laboratory on the day of collection by
the authors. Urine samples had creatinine content analysed upon
arrival by the Jaffe alkaline picrate method (Cocker et al., 2011) on a
Pentra 400 spectrophotometer (Horiba UK Ltd, Northampton, UK).
Creatinine (a breakdown product of creatine phosphate in muscle,
which is usually produced at a constant rate by the body) allows
a urine sample to be normalised for hydration. Both urine sam-
ples and EBC samples were refrigerated at between 2 and 8 ◦C until
analysis.
2.5. Sample preparation and analysis
2.5.1. EBC samples – chromium speciation
A single mobile phase was  prepared in water by adding 4%
v/v ammonia solution and 3.2% v/v ultrapure nitric acid pH was
adjusted to between pH 1.8–2 using the ammonia solution.
Exhaled breath condensate samples were allowed to reach room
temperature and mixed on a roller mixer before analysis. The sam-
ples were analysed in duplicate. For the calibration standards, stock
solutions of 1000 mg/L of Cr(III) and Cr(VI) were prepared in water.
Using these 1000 mg/L stock solutions a 100 g/L mixed species
working solution was  prepared in water. Using the 100 g/L mixed
species working solution, standards of 0.01, 0.02, 0.05, 0.1, 0.5, 1
and 2 g/L were prepared in the 0.5 mM EDTA solution, giving a
linear calibration range up to 20 g/L. Samples above the linear cal-
ibration range were diluted further with the 0.5 mM EDTA solution
where necessary
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A commercially available proﬁciency testing material (PTM) was
btained from Sigma Aldrich (Dorset, UK) for Cr(VI) in drinking
ater (sample 1045/PE1453, Lot LRAA1427). This PTM was  within
ate with a certiﬁed range. Whilst the manufacturer’s instructions
uggest the PTM is diluted 100 fold in water, for the purpose of
his study the PTM was diluted 1000 fold in water to more accu-
ately reﬂect the levels of total chromium and Cr(VI) in EBC samples
reviously reported (Caglieri et al., 2006; Goldoni et al., 2010).
It was also necessary to collect a large volume of EBC from a vol-
nteer not occupationally exposed to Cr(VI) to create an EBC blank
ample and spike to use as an in-house quality control material.
hree equal volumes of “blank” EBC were spiked to create three
n-house controls: 2 g/L Cr(III), 2 g/L Cr(VI) and a mixed 2 g/L
r(III) and Cr(VI) EBC sample.
Both the 1000 fold dilution of the PTM and the 2 g/L in-house
piked EBC samples were diluted 10 fold with 0.5 mM EDTA solu-
ion for analysis and refrigerated at between 2 and 8 ◦C for up to 6
eeks between analyses, as per the storage stability study under-
aken by Leese et al. (2016). The PTM and the spiked EBC samples
ere analysed at the beginning and the end of the analytical run as
ell as every 10 samples.
.5.2. Urine samples – total chromium
For total chromium analysis, a single standard stock solution of
 mg/L chromium was prepared in water from the 1000 mg/L single
tandard. Using the 1 mg/L stock solution, standards of 0.5, 2.5, 5,
0 and 20 g/L were prepared in water, giving a linear calibration
p to 80 g/L.
Urine samples were allowed to reach room temperature and
ixed on a roller mixer before analysis. Samples were diluted 20
old and calibration standards 5 fold with a 1% v/v nitric acid solu-
ion containing 10 g/L Ge internal standard, following the Health &
afety Laboratory UKAS accredited method for total chromium in
rine. The certiﬁed reference materials (CRMs) were Lyphocheck
rine metals control Level 1 (Lot 69161 & 69171) (Bio-RAD Lab-
ratories, Hemel Hempstead, UK) and Clinchek urine control for
race elements Level 2 (Lot 122 & 432) (Recipe, Munich, Germany)
nd were analysed like the urine samples at the beginning and the
nd of each analytical run and after every 20 samples. In addition,
 2 g/L standard was analysed at the beginning and end of each
nalytical run as well as every 10 samples to monitor drift within
he analysis.
. Results
.1. Analytical method & validation
.1.1. EBC samples – chromium speciation
The method described in this study is a sensitive and robust
ethod for the determination of Cr(III) and Cr(VI) in EBC sam-
les. The chromatograms in Fig. 1 show that this novel speciation
ethod can reproducibly separate Cr(III) and Cr(VI) in both aqueous
tandards and an EBC matrix within 2 min  20 s (200,000 ms).
Based upon the results of twenty two analyses of the determi-
ation of chromium species in EBC samples, the limit of detection
LOD) and limit of quantiﬁcation (LOQ) have been established for
oth Cr(III) and Cr(VI). The LOD were calculated as three times the
tandard deviation of the mean of the blank; these were 0.007 g/L
nd 0.002 g/L for Cr(III) and Cr(VI) respectively. The LOQ were
alculated as ten times the background equivalent concentration
BEC); these were 0.067 g/L and 0.008 g/L for Cr(III) and Cr(VI)
espectively. The results of the three in-house spiked EBC sam-
les shown in Table 2 gave an average spiked recovery of 105%
or the EBC sample spiked only with 2 g/L Cr(III); 98% for the EBC
ample spiked only with 2 g/L Cr(VI), along with 99% and 95% for Environmental Health 220 (2017) 415–423
the EBC sample spiked with both 2 g/L Cr(III) and Cr(VI) respec-
tively. In each analysis the PTM for Cr(VI) in water gave consistently
accurate results which were all within the acceptance range. As
shown in Table 2, no conversion of chromium species was observed
during analysis with the Cr(III) concentrations less than the LOQ
when measuring the PTM and EBC in-house sample spiked only
with 2 g/L Cr(VI) (no Cr(III) should be present). The Cr(VI) con-
centration was also less than the LOQ when measuring the EBC
in-house sample spiked only with 2 g/L Cr(III) (no Cr(VI) present).
3.1.2. Urine samples – total chromium
The determination of total chromium in urine is an established
UKAS accredited method at the Health and Safety Laboratory. The
LOD is 1 nmol/L (0.05 g/L) (uncorrected for creatinine). Both urine
CRMs, Biorad Level 1 and Clinchek level 2 are certiﬁed for total
chromium in urine; all gave good results within the target range,
this is shown in Table 2.
3.2. Study results
Of the 22 volunteers (16 males, 6 females) in the control group
only 1 (male) was a smoker, the remaining 21 volunteers were
non-smokers. Of the 58 volunteers (53 males, 5 females) in the
occupationally exposed worker group, 33 were non-smokers (3
female, 29 male) and 25 were smokers (1 female, 24 male). Of these
58 workers, 35 were classiﬁed as Cr(VI) Workers, 12 as Non-Cr(VI)
Workers and 11 as Other Workers. Of the 35 Cr(VI) Workers only 1
volunteer was female, similarly of the 12 Non-Cr(VI) Workers only
1 volunteer was  female. Of the 11 Other Workers 3 volunteers were
female and 8 were male.
The EBC results for controls and workers are shown in Fig. 2
and presented in Table 3. The results for the EBC analysis from the
control group showed that 84% and 91% were below the LOQ for
Cr(III) and Cr(VI) respectively, compared with only 5% and 3% for
the occupationally exposed workers.
Fig. 2 and Table 3 show that the median values for Cr(III) in
EBC from the control group are below the LOQ. Furthermore all
Cr(III) found in EBC results from a Non-Cr(VI) worker or Other
Worker were above the LOQ. The median concentration of Cr(III)
in EBC samples for both pre and post working week of all 58 occu-
pationally exposed workers is very similar, with a median value
of 0.59 g/L for pre working week and 0.54 g/L for post working
week. The Cr(VI) Workers also showed similar median concentra-
tions of Cr(III) in EBC of 0.58 g/L and 0.51 g/L for pre and post
working week samples respectively. The Other Workers had the
highest median concentrations of Cr(III) in EBC of 0.70 and 0.66 g/L
for pre and post working week samples. The Non-Cr(VI) Workers
gave the lowest median concentrations of pre and post working
week samples for Cr(III) in EBC of 0.38 and 0.54 g/L respectively.
The maximum Cr(III) concentration measured was 11.02 g/L and
was from a post working week EBC sample of a Cr(VI) Worker, com-
pared to the maximum Cr(III) in EBC from a Non-Cr(VI) Worker and
an Other Worker both resulting from a pre working week sample,
of 9.1 g/L and 2.97 g/L respectively.
Fig. 2 and Table 3 show that the median values for Cr(VI) in EBC
from the control group are below the LOQ. As with Cr(III), there
were no Cr(VI) in EBC results from a Non-Cr(VI) worker or Other
Worker less than the LOQ. The results of Cr(VI) in EBC samples for
all 58 occupationally exposed workers showed a median concen-
tration increase from 0.58 to 0.72 g/L of pre to post working week
samples. An increase in Cr(VI) EBC levels was observed between
the pre and post working samples for both median (0.72–0.91 g/L)
and 90th percentile concentrations (2.81–4.56 g/L) for the Cr(VI)
Workers. This trend was also observed in the Non-Cr(VI) Workers
to a lesser extent with a pre working week median concentration of
0.29 g/L increasing to a post working week median concentration
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Wig. 1. Chromatograms showing full separation of EDTA-Cr(III) and Cr(VI) using an E
itric  acid and ammonia mixed mobile phase. (A) Overlay of the individual standar
 g/L mixed Cr(III) and Cr(VI). (C) An EBC sample from an occupationally exposed 
f 0.44 g/L. A two-fold increase from 0.31 g/L (pre working week)
o 0.62 g/L (post working week) was observed in the median EBC
f the Other Workers. The Other Workers showed a higher median
nd 90th percentile for both the pre and post working week Cr(VI)
n EBC samples than the Non-Cr(VI) Workers, but not the Cr(VI)
orkers. The maximum Cr(VI) concentration in EBC of 27.3 g/LeFAST system coupled to a Dionex AG7 anion exchange column and ICP-MS using a
ration chromatograms of 0–2 g/L calibration. (B) An in-house spiked EBC sample
teer.
was from the same Cr(VI) Worker’s post working week EBC sample
that contained the highest Cr(III) concentration in EBC. Similarly to
Cr(III) in EBC the highest level of Cr(VI) in both Non-Cr(VI) Workers
and Other Workers was from a pre working week sample, of 8.31
and 2.59 g/L respectively.
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Table 2
Results obtained for the two  species of chromium in the in house spiked EBC samples and the PTM samples and the urinary chromium CRM.
In-house spiked EBC (2 g/L)
Cr(III) (n = 58) (% recovery)
In-house spiked EBC (2 g/L)
Cr(VI) (n = 56) (% recovery)
In-house spiked EBC (2 g/L) Cr(III)
& Cr(VI) mix  (n = 58) (% recovery)
PTM LRAA1427 (n = 57)
Target range 2.28–3.28
Cr(III) EBC 2.09 ± 0.3 (105%) <LOQ 1.98 ± 0.26 (99%) <LOQ
Cr(VI) EBC <LOQ 1.95 ± 0.16 (98%) 1.90 ± 0.26 (95%) 2.63 ± 0.17
Biorad Level 1–69161 (n = 14)
Target range 0.359–0.995 g/L
Biorad Level 1–69171 (n = 35)
Target range 0.575–2.53 g/L
Clinchek Level 2–122 (n = 18)
Target range 16.2–24.4 g/L
Clinchek Level 2–432 (n = 31)
Target range 15.9–23.8 g/L
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0.82 ± 0.09 0.90 ± 0.16 
All of the urinary total chromium results for the occupationally
xposed workers were above the limit of quantiﬁcation. As shown
n Fig. 3 all the urine samples from the control group were below
he HSL background unexposed reference range of <2.9 mol/mol
reatinine.
Analysis of the urine samples from the occupationally exposed
orkers showed; that 53% were below the background unex-
osed reference range, 31% were above the HSL UK background
nexposed reference range but below the BMGV of 10 mol/mol
reatinine whilst 16% exceeded the BMGV. As shown in Table 3, the
edian values for all 58 workers of the occupationally exposed
roup showed a moderate increase in total chromium in urine
rom 1.9 to 3.3 mol/mol creatinine for pre to post working week
amples. However, the 90th percentile values showed over a 4-
old increase from 3.1 to 13.7 mol/mol creatinine for pre to post
orking week samples. The increase of the median and 90th per-
entile from the pre working week samples to the post working
amples was also observed for all three categories of worker, with
 signiﬁcant increase observed in the 90th percentile for both
r(VI) Workers and Non-Cr(VI) Workers from pre to post work-
ng week samples. The highest urinary total chromium value was
ound in a post working week sample of a Non-Cr(VI) Worker,
eing 37.1 mol/mol creatinine, compared to maximum value of
.0 mol/mol creatinine for an Other Worker. The highest urinary
otal chromium value for both pre and post working week from a
r(VI) worker was 29.4 and 34.1 mol/mol creatinine respectively
nd came from the same volunteer. However this volunteer was  not
esponsible for the highest Cr(III) and Cr(VI) levels found in EBC.
.3. Statistical resultsGeneral statistical analysis was performed using Prism Graph-
ad Version 6 for Windows. Due to the skewness and distribution
rom normality of the data, all the data was log transformed. The log
able 3
tatistical summary of the mean, median and 90th percentile concentrations of pre work
r(VI)  in EBC in g/L and total chromium in urine in mol/mol creatinine for both contro
Cr(III) in EBC g/L 
Pre W-Wk  Post W-Wk  Pre W
All Workers:
n = 58
Median
P90
Range
0.59
2.43
0.19–9.1
0.54
4.21
0.14–11.03
0.58
2.01
0.04–
Cr(VI) Workers:
n = 35
Median
P90
Range
0.58
2.15
<LOQ-3.38
0.51
2.98
<LOQ-11.02
0.72
2.81
<LOQ
Non  Cr(VI)
Workers
n = 12
Median
P90
Range
0.38
0.86
0.19–9.1
0.54
1.41
0.20–4.56
0.29
0.76
0.04–
Other Workers
n = 11
Median
P90
Range
0.70
2.2
0.27–2.97
0.66
2.05
0.14–2.21
0.31
2.01
0.03–
Controls
n  = 22
Median
P90
Range
<LOQ
0.09
<LOQ–0.27
<LOQ
0.09
<LOQ–4.97
<LOQ
0.01
<LOQ18.9 ± 1.20 18.6 ± 0.75
of the data is normally distributed enabling parametric statistical
analysis. Results below the LOQ were replaced with half the LOQ.
Paired t-tests showed there was  a signiﬁcant difference for total
chromium levels in urine between pre and post working week sam-
ples for all the occupationally exposed workers (p = 0.03). However
there was  no signiﬁcant difference between pre and post working
week EBC samples for Cr(III) (p = 0.63) or Cr(VI) (p = 0.13). Unpaired
t-tests found there was a strong signiﬁcant difference between
workers and controls for total chromium in urine (p < 0.0001), as
well as Cr(III) in EBC samples (p < 0.0001) and Cr(VI) in EBC samples
(p < 0.0001). As demonstrated in Fig. 4, no correlation was found
when comparing post working week levels of total chromium in
urine with Cr(III) in EBC (r2 = 0.02, p = 0.35), or post working week
levels of total chromium in urine samples with the sum of Cr(III)
and Cr(VI) in EBC samples (r2 = 0.04, p = 0.12). However, a weak
moderate correlation was  observed when comparing post working
week levels of total chromium in urine with Cr(VI) in EBC samples
(r2 = 0.11, p = 0.01).
Statistical analysis was  not performed for gender differences
because of the small proportion (9%) of females forming the occu-
pationally exposed group in this study. There was also no statistical
signiﬁcant difference observed between smokers and non-smokers
or between workers who  wore facemasks/respiratory protective
equipment (RPE) and those who  did not.
4. Discussion
Reported here are the determined chromium speciation results
of Cr(III) and Cr(VI) concentrations in EBC and total chromium
concentrations in urine from pre and post working week samples
collected from 58 occupationally exposed workers and 22 controls
not occupationally exposed to chromium.
The LOD and LOQ reported in this novel chromium speciation
study are very low, thus making this a suitable method for the
ing week (Pre W-Wk)  and post working week (Post W-Wk)  samples for Cr(III) and
ls and workers.
Cr(VI) in EBC g/L Total Cr in Urine mol/mol creatinine
-Wk  Post W-Wk  Pre W-Wk  Post W-Wk
9.69
0.72
2.45
0.01–27.3
1.9
3.1
0.5–29.4
3.3
13.7
0.6–37.1
-9.69
0.91
4.56
<LOQ-27.3
3.4
14.8
0.6–29.4
4.7
20.4
1.1–34.1
8.31
0.44
1.71
0.06–2.45
1.5
3.7
0.6–8.6
2.1
23.7
0.6–37.1
2.59
0.62
1.84
0.01–2.20
1.2
1.6
0.5–5.1
1.5
2.7
0.8–6.0
–0.07
<LOQ
<LOQ
<LOQ-0.12
0.4
0.6
<LOQ-1.3
0.4
1.1
<LOQ-1.4
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Fig. 2. Scatter plots with median concentrations (g/L) from pre working week
(Pre W-Wk)  to post working week (Post W-Wk)  samples for (A) Cr(III) in EBC and
(B) Cr(VI) in EBC for both occupationally exposed volunteers and the unexposed
control group.
Fig. 3. Scatter plot showing the results of total chromium in urine (mol/mol creati-
nine) for both the occupationally exposed workers and the control group for both pre
working week (Pre W-Wk)  and post working week (Post W-Wk)  samples. Showing
results in comparison to the background unexposed reference range and the BMGV.
Fig. 4. Correlations of log transformed data between post working week total
chromium in urine and; (A) Cr(III), (B)Cr(VI) and (C) the sum of Cr(III) and Cr(VI)
in  post working week EBC samples.
analysis of EBC where median concentration of Cr(III) and Cr(VI)
were found to be less than 2 g/L. No other studies have published
actual Cr(III) results in EBC samples, only Cr(VI) and total chromium
so there are no LOD/LOQ values to compare against. The Cr(VI)
LOD and LOQ reported here is lower than other reported stud-
ies (Goldoni et al., 2010; Goldoni et al., 2006). However, the LOD
and LOQ reported in this study are achieved using ICP-MS whilst
the LOD of 0.2 g/L reported by Goldoni et al. (2010, 2006) uses
electrothermal atomic absorption spectrometry (ETAAS). Other
publications reporting chromium in EBC were for total chromium
only and the LODs reported were a limiting factor in their results
(Gube et al., 2010; Hoffmeyer et al., 2011).
The background unexposed reference range established by the
Health and Safety Laboratory, for total chromium in urine is
<2.9 mol/mol creatinine (Morton et al., 2014). For the urinary total
chromium results for exposed workers, 47% exceeded this value,
indicating that nearly half of the urine samples provided by the
58 workers showed some occupational exposure to Cr(VI) com-
pounds. Furthermore, 16% were above the BMGV of 10 mol/mol
creatinine, indicating that 19 urine samples provided by the 58
workers showed signiﬁcant exposure to Cr(VI) compounds. This
exposure demonstrates that the occupationally exposed workers
who took part in this study were a suitable cohort to success-
fully meet the objective of this study and determine if Cr(III) and
Cr(VI) could be detected and measured in real EBC samples. As
shown in Table 3, the 90th percentile of urinary total chromium
for both Other Workers and the control group are within the back-
ground unexposed reference range, whereas the Cr(VI) Workers
and Non-Cr(VI) Workers is twice the BMGV of 10 mol/mol creati-
nine, indicating a strong association with chromium occupational
exposure and urinary chromium measurements.
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It is important to note that the study outlined here was a pilot
easibility study to ascertain if both Cr(III) and Cr(VI) could be deter-
ined in EBC samples from workers occupationally exposed to
r(VI) compounds by inhalation. Consequently, no environmental
onitoring such as air monitoring, surface wipes or hand wipe sam-
ling was performed, nor was information taken regarding length
f time since last potential exposure or length of time and levels of
otential exposure from any of the occupationally exposed workers
rior to providing a EBC or urine sample.
The statistical analysis found a lack of correlation between lev-
ls of total chromium in urine with Cr(III) in EBC and levels of
otal chromium in urine with the sum of Cr(VI) and Cr(III) in
BC, however a low moderate correlation was found between lev-
ls of total chromium in urine with Cr(VI) in EBC. This lack of
orrelation is in agreement with other studies where no correla-
ion was found between total chromium in urine with Cr(VI) in
BC (Goldoni et al., 2006) or with total chromium in urine com-
ared with total chromium in EBC (Caglieri et al., 2006; Goldoni
t al., 2010). However, this may  be expected considering urinary
hromium levels will reﬂect all three routes of exposure (inhalation,
ermal and ingestion); whereas EBC samples will reﬂect mainly
nhalation exposure with some contribution from what is present
n the mouth but not exposure by dermal absorption or ingestion.
nterestingly, Goldoni et al. (2010) found there was  a signiﬁcant
orrelation between total chromium in post shift EBC samples and
BC samples only. This is not always the case, as better correlation
f urine with EBC samples has been observed for other elements
Goldoni et al., 2004).
Whilst there is a lack of statistical signiﬁcance between the pre
nd post working week samples for both Cr(III) and Cr(VI) in EBC, all
he levels were higher than the controls. The data showed that 48%
f the occupationally exposed group showed an increase of the con-
entrations of Cr(III) in EBC from the pre to post work week sample,
nd 59% showed an increase of the concentrations of Cr(VI) in EBC
rom the pre to post working week sample. However, chromium
n lungs has shown to accumulate upon repeat inhalation (Hoet,
005), something that is likely to happen in an occupational set-
ing. In addition, reduction of Cr(VI) to Cr(III) by glutathione was
ound to be much slower than ascorbate leading to a longer res-
dence of chromium in lungs (Petersen et al., 2000), meaning the
igher levels of chromium in pre working week EBC samples may
e the result of high exposure the previous week. It must also be
oted that although both urine and EBC samples collected on the
onday morning were considered pre working week, the workers
ad already entered the work place. Although workers had been
nstructed not to start ofﬁcial work that could result in inhalation
xposure (e.g. grinding or electroplating), they had started pre work
reparation, meaning some exposure may  have already occurred
rom chromium levels in the air of the workplace or from prepa-
ation procedures. This lack of correlation may  also be related to
he combination of a high proportion of low g/L values for a sam-
le size of only 58 occupationally exposed workers. In addition,
he lack of information regarding exposure of the workers prior
o providing the post working week EBC sample will be a con-
ributing factor. No statistically signiﬁcant difference was  found
etween smokers and non-smokers for Cr(III) or Cr(VI) in EBC or
otal chromium in urine. Nor was there a statistical signiﬁcant dif-
erence found between those individuals that wore any type of
acemask/respiratory protective equipment (RPE) and those that
id not. However, this outcome is not unexpected when tandem
nvironmental analysis has not been performed and little informa-
ion is known on length of time since last exposure or length of
ime the worker has experienced Cr(VI) exposure or the levels of
xposure. This uncertainty, along with the fact these comparisons
ould reduce the dataset substantially, make it difﬁcult to com-
are these more speciﬁc data groups and extrapolate any type of Environmental Health 220 (2017) 415–423
signiﬁcance that would be statistically robust to investigate as to
whether wearing RPE or smoker status affected observed levels of
Cr(III) or Cr(VI) in EBC samples.
A similar study by Goldoni et al. (2006), determined Cr(VI)
in EBC samples from 10 chromium electroplaters; they looked
at overnight chromium decrease with EBC samples taken post
shift and again the following morning pre shift (15 h since expo-
sure). A decrease in Cr(VI) levels from overnight post to pre shift
was observed, with concentrations of Cr(VI) found in EBC sam-
ples ranging from 0.1–2.9 g/L for the post shift EBC samples and
0.1–2.1 g/L for the pre shift EBC samples. However only 10 work-
ers were sampled and seven of the 20 EBC samples collected were
found to be below the LOD. The concentrations of Cr(VI) in EBC
reported here in the current study were higher, with overall (n = 58)
concentrations of Cr(VI) in workers ranging from 0.04–9.69 g/L for
the pre shift EBC samples and 0.01–27.35 g/L for the post shift EBC
samples. A later study by Goldoni et al. (2010) reported a similar
study method but with tandem urine, red blood cell and plasma
sampling alongside the EBC sample collection. The median values
reported in this later study compare well with the results reported
here in this study. For example, median total chromium in urine
levels increased from 4 to 6 mol/mol creatinine in Goldoni’s study
compared to a median increase of 1.9–3.3 mol/mol creatinine for
all workers and 3.4–4.7 mol/mol creatinine for Cr(VI) Workers
reported here in this study. Additionally, in Goldoni’s study median
values for Cr(VI) in EBC samples increased from 0.3 to 1.0 g/L com-
pared to median values increasing from 0.58 to 0.72 g/L for all
workers and 0.72–0.91 g/L for Cr(VI) Workers reported here in
this study. The studies by Goldoni et al. (2006, 2010) in addition
to the work reported here indicate the need for a comprehensive
EBC collection protocol to better understand dwell, half-life and
excretion rates of chromium in EBC.
Also of interest is the two fold increase of 0.31 g/L (pre working
week) to 0.62 g/L (post working week) median levels of Cr(VI) in
EBC for the Other Workers. Although the median values are not
higher than the Cr(VI) Workers, they are higher than the median
values of the Non-Cr(VI) Workers, indicating inhalation exposure
is not limited solely to workers operating directly in areas of the
workplace where chromium processes occur. Chromium exposure
of Other Workers is more evident when the median values for both
Cr(III) and Cr(VI) in EBC are compared against the control group
values, which were all below the LOQ, however there were only
11 volunteers in the Other Workers group. No other studies have
determined chromium EBC measurements in this type of worker
cohort for comparison.
In recent literature, there is reference to the need for a marker
in EBC samples to standardise for dilution (Kuban and Foret, 2013;
Rosias, 2012), in the same way creatinine is utilised to correct for
concentration of urine. It is suggested that the droplets of ﬂuid from
the respiratory tract can be diluted by the water vapour found in
EBC and will vary amongst individuals (Rosias, 2012). At present,
there is no consensus on a suitable and accurate biomarker to cor-
rect for dilution, as smoking status, inﬂammatory conditions such
as asthma or the inhaled contaminant itself have affected their use-
fulness in biomarkers studies (Dodig and Cepelak, 2013; Hoffmeyer
et al., 2015). However Rosias (2012) and Reinhold and Knobloch
(2010) have suggested EBC results be expressed per volume of
EBC collected. Unfortunately, in this study neither approach was
explored. However, it is something that must be taken into consid-
eration in future EBC studies.
To enable the future of EBC as a biomarker for occupational
exposure to chromium species there needs to be an understanding
of the dwell time of chromium species detectable in an EBC sample
after exposure has ceased. In addition to a better understanding
of the relationship between levels of exposure and EBC measure-
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ir measurements.
Previously known CRMs for either Cr(III) and/or Cr(VI) by NIST
nd IRMM have either been discontinued or withdrawn. For the
uture success of chromium speciation in EBC it is important that
RMs in either water or EBC are made available. In addition, the
uture of EBC as a biological matrix will rely on CRMs for other
race elements.
. Conclusion
This is the ﬁrst study to report the detection and measurement
f Cr(III) and Cr(VI) in ‘real’ exhaled breath condensate (EBC) sam-
les of volunteers. The analytical method outlined in this feasibility
tudy has shown that both Cr(III) and Cr(VI) can be simultaneously
etected and measured in EBC samples from a cohort of volunteers
ho are occupationally exposed to Cr(VI) compounds by inhalation.
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o statistically signiﬁcant difference was found between pre and
ost working week samples for Cr(III) and Cr(VI) in EBC of the occu-
ationally exposed workers. The speciation method demonstrates
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ext stage of this study will be to undertake site visits to perform air
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tand and correlate the relationship between levels of exposure and
BC results for chromium.
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